-
【Movie】The micellar nanoparticle technology
| Products | PC | phaseⅠ | phaseⅡ | phaseⅢ |
|---|---|---|---|---|
| VB-111 Non-replicating Adeno 5 vector |
||||
|
Ovarian cancer（USA/Israel/EU/Japan）
Combination therapy with Paclitaxel |
||||
| Co-Development Partner：VBL（Israel） |
||||
|
rGBM
|
||||
| Investigator-initiated（USA） | ||||
|
Colorectal Cancer
|
||||
| Operation by NCI/VBL（USA） | ||||
| ENT103 ENT product |
||||
|
Otitis media（Japan）
|
||||
| Co-Development Partner：CEOLIA PHARMA（Japan） |
||||
| NC-6004 Cisplatin micelle |
||||
|
Head and Neck cancer（EU/Taiwan）
Combination therapy with Kyet ruda® |
||||
| Co-Development Partner：Orient Europharma（Taiwan） |
||||
| NC-6300 Epirubicin micelle |
||||
|
Soft tissue sarcoma（USA）
|
||||
| In-House Development FDA Orphan drug designation |
||||
| NC-6100 PRDM14 (siRNA) |
||||
|
HER2-negative breast cancer
(Japan) |
||||
| Investigator-initiated | ||||
| TUG1 (ASO) | ||||
|
GBM (Japan)
|
||||
| Collaboration with NAGOYA University | ||||
| RUNX1 (mRNA) | ||||
|
Osteo arthritis
(Japan) |
||||
| PrimRNA Partner：Axcelead Inc. |
||||
